| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 119.5 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 119.5. The average price that BIM.PA shares were previous bought at was EUR 110.633. The current market price is 8.0% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 21,432 compared to the previous valuation of BioMerieux |
| RO.SW - | HOLD | 0 @ CHF 296.32 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 296.32. The average price that RO.SW shares were previous bought at was CHF 302.302. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 23,099 compared to the previous valuation of |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 47.28 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 47.28. The average price that FME.DE shares were previous bought at was EUR 46.8565. The current market price is 0.9% higher than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 192,679 compared to the previous valuation of Fresenius Medical Care AG |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 60.64 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 60.64. The average price that ERF.PA shares were previous bought at was EUR 51.0554. The current market price is 18.8% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 28,148 compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 209.4 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 209.4. The average price that SRT3.DE shares were previous bought at was EUR 220.626. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 47,628 compared to the previous valuation of Sartorius AG |
| SOBI.ST - | HOLD | 0 @ SEK 25.6165 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 25.6165. The average price that SOBI.ST shares were previous bought at was SEK 26.9812. The current market price is -5.1% lower than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 55,185 compared to the previous valuation of |
| GALD.SW - | HOLD | 0 @ CHF 114.976 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 114.976. The average price that GALD.SW shares were previous bought at was CHF 104.269. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 112,387 compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 197.8 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 197.8. The average price that DIM.PA shares were previous bought at was EUR 190.197. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 76,104 compared to the previous valuation of Sartorius Stedim Biotech |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 54.25 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 54.25. The average price that REC.MI shares were previous bought at was EUR 52.548. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 20,390 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 63.05 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 63.05. The average price that ORNBV.HE shares were previous bought at was EUR 50.7131. The current market price is 24.3% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 8,579 compared to the previous valuation of Orion Oyj |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 12.631 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 12.631. The average price that SN.L shares were previous bought at was GBP 12.775. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 21,733 compared to the previous valuation of Smith & Nephew PLC |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 102.7 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 102.7. The average price that IPN.PA shares were previous bought at was EUR 107.092. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 16,321 compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 24.3828 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 24.3828. The average price that HIK.L shares were previous bought at was GBP 24.4976. The current market price is -0.5% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 14,989 compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 37.085 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 37.085. The average price that DEMANT.CO shares were previous bought at was DKK 34.1992. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 10,965 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.505 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.505. The average price that GRF.MC shares were previous bought at was EUR 10.2434. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 14,771 compared to the previous valuation of Grifols SA |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 93.44 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 93.44. The average price that DIA.MI shares were previous bought at was EUR 68.5775. The current market price is 36.3% higher than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 4,849 compared to the previous valuation of DiaSorin SpA |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 65.4283 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 65.4283. The average price that NOVO-B.CO shares were previous bought at was DKK 65.9517. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 1,732,042 compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 82.5898 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 82.5898. The average price that COLO-B.CO shares were previous bought at was DKK 92.5737. The current market price is -10.8% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 130,252 compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.605 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.605. The average price that QIA.DE shares were previous bought at was EUR 37.624. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 17,096 compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.51315 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.51315. The average price that HLN.L shares were previous bought at was GBP 4.70903. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 260,886 compared to the previous valuation of Haleon PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 27.16 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 27.16. The average price that BAYN.DE shares were previous bought at was EUR 21.9962. The current market price is 23.5% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 161,525 compared to the previous valuation of Bayer AG |
| NOVN.SW - | HOLD | 0 @ CHF 101.649 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 101.649. The average price that NOVN.SW shares were previous bought at was CHF 98.158. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 671,972 compared to the previous valuation of |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 124.985 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 124.985. The average price that AZN.L shares were previous bought at was GBP 128.315. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 1,168,164 compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 84.85 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 84.85. The average price that SAN.PA shares were previous bought at was EUR 95.2663. The current market price is -10.9% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 453,038 compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.3493 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.3493. The average price that GSK.L shares were previous bought at was GBP 16.7885. The current market price is 3.3% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 121,451 compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 240.5 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 240.5. The average price that EL.PA shares were previous bought at was EUR 248.822. The current market price is -3.3% lower than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 270,988 compared to the previous valuation of EssilorLuxottica SA |
| LONN.SW - | HOLD | 0 @ CHF 595.405 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 595.405. The average price that LONN.SW shares were previous bought at was CHF 584.866. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 226,047 compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 74.5161 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 74.5161. The average price that ALC.SW shares were previous bought at was CHF 81.3862. The current market price is -8.4% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 48,829 compared to the previous valuation of however if the holding was sold on 2025-06-17 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 472.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 472.8. The average price that ARGX.BR shares were previous bought at was EUR 551.897. The current market price is -14.3% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 249,219 compared to the previous valuation of Argenx SE |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 158.15 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 158.15. The average price that UCB.BR shares were previous bought at was EUR 171.449. The current market price is -7.8% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 190,345 compared to the previous valuation of UCB SA |
| ROG.SW - | HOLD | 0 @ CHF 278.239 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 278.239. The average price that ROG.SW shares were previous bought at was CHF 285.605. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 416,196 compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 19.5 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 19.5. The average price that PHIA.AS shares were previous bought at was EUR 22.709. The current market price is -14.1% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 98,631 compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 112.1 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 112.1. The average price that MRK.DE shares were previous bought at was EUR 130.164. The current market price is -13.9% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 130,560 compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 45.0968 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 45.0968. The average price that SDZ.SW shares were previous bought at was CHF 40.3939. The current market price is 11.6% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 20,627 compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 261.115 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 261.115. The average price that SOON.SW shares were previous bought at was CHF 291.912. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 98,232 compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 45.87 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 45.87. The average price that SHL.DE shares were previous bought at was EUR 48.2129. The current market price is -4.9% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 22,792 compared to the previous valuation of Siemens Healthineers AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 43.01 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 43.01. The average price that FRE.DE shares were previous bought at was EUR 37.9992. The current market price is 13.2% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 162,334 compared to the previous valuation of Fresenius SE & Co KGaA |
| GMAB.CO - | HOLD | 0 @ DKK 193.201 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 193.201. The average price that GMAB.CO shares were previous bought at was DKK 190.425. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 114,336 compared to the previous valuation of |
| STMN.SW - | HOLD | 0 @ CHF 110.987 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 110.987. The average price that STMN.SW shares were previous bought at was CHF 118.249. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 60,795 compared to the previous valuation of |